-
88Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International RegulationsJournal of Bioethical Inquiry 14 (2): 261-273. 2017.Cell and tissue-based products, such as autologous adult stem cells, are being prescribed by physicians across the world for diseases and illnesses that they have neither been approved for or been demonstrated as safe and effective in formal clinical trials. These doctors often form part of informal transnational networks that exploit differences and similarities in the regulatory systems across geographical contexts. In this paper, we examine the regulatory infrastructure of five geographically…Read more
-
71Procedural Ethics and the European Stem Cell DebateJahrbuch für Wissenschaft Und Ethik 11 (1): 41-66. 2006.
-
61Human Enhancement Technologies: Understanding Governance, Policies and Regulatory Structures in the Global ContextAsian Bioethics Review 4 (4): 251-258. 2012.
-
58A Brief Critique of Two Claims about the Social Value of Biotechnological EnhancementsAsian Bioethics Review 4 (4): 259-271. 2012.
-
83Treating Minors and the Duty to Disclose Information to ParentsAsian Bioethics Review 5 (3): 255-261. 2013.
-
72Expanding a Shared Benefit Approach in One Health ResearchAmerican Journal of Bioethics 18 (10): 47-49. 2018.
-
77Standing at the Precipice: A Cautionary Note About Incremental GoodsAmerican Journal of Bioethics Neuroscience 1 (3): 46-48. 2010.Vedder and Klaming (2010) argue that current debates on the use of neurotechnologies for cognitive enhancement have stalled because of a preoccupation with an egotistic conception of ethics. They a...
-
Public goods in the ethical reconsideration of research innovationIn Patrick Capps & Shaun D. Pattinson (eds.), Ethical rationalism and the law, Hart Publishing. 2017.
-
60Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open CommonsCambridge Quarterly of Healthcare Ethics 30 (1): 11-24. 2021.During the 2020 COVID-19 pandemic, open science has become central to experimental, public health, and clinical responses across the globe. Open science is described as an open commons, in which a right to science renders all possible scientific data for everyone to access and use. In this common space, capitalist platforms now provide many essential services and are taking the lead in public health activities. These neoliberal businesses, however, have a problematic role in the capture of publi…Read more
-
39Redefining Property in Human Body Parts: An Ethical EnquiryIn Akira Akabayashi (ed.), The Future of Bioethics: International Dialogues, Oxford University Press. pp. 235. 2014.
-
57One Health Requires a Theory of AgencyCambridge Quarterly of Healthcare Ethics 31 (4): 518-529. 2022.One health suggests that human and animal health are comparable, but in practice, the concept aligns with the principles of public health ethics. One health ethics, as such, appears to eschew connotations of equality for the natural world. A theory of agency revises that anthropocentric assumption. This article begins with a critique of environmental dualism: the idea that human culture and nature are separate social realms, thus justifying public health as a (unifying) purpose. In response, thi…Read more
-
53The Ecological Genome Project and the Promises of Ecogenomics for Society: Realising a Shared Vision as One HealthBioethics 39 (9): 788-795. 2025.This paper develops a vision for The Ecological Genome Project: an aspirational, global endeavour to connect human genomic sciences with the ethos of ecological sciences. The Project's goal is to strengthen interdisciplinary networks that relate to diverse initiatives using genomic technologies, with respect to shared ethical frameworks and governance structures. To this end, this paper proposes a practical definition of ecogenomics to align various methodologies and values in a single environme…Read more
-
65The European Union and stem cell research: a turnaround on policy regarding human embryo research?Legal Ethics 5 (1-2): 1-2. 2002.
-
122Introducing One Health to the Ethical Debate About Zoonotic Diseases in Southeast AsiaBioethics 29 (8): 588-596. 2015.Pandemic plans recommend phases of response to an emergent infectious disease outbreak, and are primarily aimed at preventing and mitigating human-to-human transmission. These plans carry presumptive weight and are increasingly being operationalized at the national, regional and international level with the support of the World Health Organization. The conventional focus of pandemic preparedness for EIDs of zoonotic origin has been on public health and human welfare. However, this focus on human…Read more
-
50What Do Chimeras Think About?Cambridge Quarterly of Healthcare Ethics 32 (4): 496-514. 2023.Non-human animal chimeras, containing human neurological cells, have been created in the laboratory. Despite a great deal of debate, the status of such beings has not been resolved. Under normal definitions, such a being could either be unconventionally human or abnormally animal. Practical investigations in animal sentience, artificial intelligence, and now chimera research, suggest that such beings may be assumed to have no legal rights, so philosophy could provide a different answer. In this …Read more
-
8Response to CommentariesIn Akira Akabayashi (ed.), The Future of Bioethics: International Dialogues, Oxford University Press. pp. 278-283. 2014.This is a response to three commentaries on the paper: “Redefining Property in Human Body Parts: An Ethical Enquiry”. In that paper, the author argued that the reasoning in the John Moore case (1998) comes unstuck in respect to a future of bioengineered organs and tissues. In this imagined future, the author argues that, instead, rights ought to define the relationships between ourselves and property. Across all three commentaries one finds reference to dignity. The author uses this opportunity …Read more
-
116One Health and paradigms of public biobankingJournal of Medical Ethics 41 (3): 258-262. 2015.In this paper, the authors consider the idea of the public biobank governance framework with respect to the innovative paradigm of One Health. The One Health initiative has been defined as an integrative and interdisciplinary effort to improve the lives and well-being of human beings and non-human animals, as well as to preserve the environment. Here, we use this approach as a starting presumption with respect to institutional design. We examine the theoretical and legal framework underlying the…Read more
-
103One health ethics: a response to pragmatismJournal of Medical Ethics 46 (9): 632-633. 2020.Johnson and Degeling have recently enquired whether one health requires a comprehensive normative framework, concluding that such a framework, while not necessary, may be helpful. In this commentary, we provide a context for this debate, and describe how pragmatism has been predominant in the OH literature. We nevertheless argue that articulating a comprehensive normative theory to ground OH practice might clear existing vagueness and provide stronger guidance in relevant health dilemmas. A comp…Read more
-
76Responding to a Public Health Objection to Vaccinating the Great ApesJournal of Agricultural and Environmental Ethics 29 (5): 883-895. 2016.Capps and Lederman, in a paper published in this journal in 2015, argued that, at the time, the dismal circumstances of the Ebola outbreak in West Africa was an opportunity to revisit public health responses to emergent infectious diseases. Using a One Health lens, they argued for an ecological perspective—one that looked to respond to zoonoses as an environmental as well as public health concern. Using Ebola virus disease as an example, they suggested shared immunity as a strategy to vaccinate …Read more
-
73Philosophy is Still Missing from the Human-Mouse Chimera DebateAmerican Journal of Bioethics 21 (1): 61-63. 2021.Given the broad coverage of “Human Brain Surrogates Research: The Onrushing Ethical Dilemma,” this commentary focuses on the section “human/nonhuman brain chimeras,” and specifically, the questions...
-
271The Public Interest, Public Goods, and Third-Party Access to UK BiobankPublic Health Ethics 5 (3): 240-251. 2012.In 2007, the Ethics and Governance Council of the UK Biobank commissioned a Report on ‘Concepts of Public Good and Pubic Interest in Access Policies’. This study considered the Biobank’s role as a ‘public good’ in respect to supporting and promoting health throughout society. However, the conditions under which access by third parties to UK Biobank are justified in the public interest have not been well considered. In this article, I propose to analyse the conditions that should allow such acces…Read more
-
100Regulating Induced Pluripotent Stem Cells Ethically in the Bio-Economy: A Preliminary EnquiryAsian Bioethics Review 6 (3): 208-233. 2014.
-
9Primary Topic ArticleIn Akira Akabayashi (ed.), The Future of Bioethics: International Dialogues, Oxford University Press. pp. 235-263. 2014.Legal property in human cells and tissues is subject to the reasoning of _Moore_ (1998). John Moore’s claim that he had property in the cells taken from his body without his consent was rejected; but in doing so, this set up the curious circumstance in which no one can _own_ the cells removed from their own body, yet anyone else who is capable of applying skill to them can. In this paper, the author takes another look at the Judges’ ethical reasoning, and cast new critical light upon it in respe…Read more
-
143Understanding risk: psychosis and genomics research in SingaporeGenomics, Society and Policy 8 (2): 1-14. 2012.This is an exploratory paper of the ethical implications for genomic research and mental illness with specific reference to Singapore. Singapore has a unique context due to its social and political systems, and although it is a relatively small country, its population is religiously and culturally diverse. The issues that we identify here, therefore, will offer new perspectives and will also shed light on the existing literature on psychiatric genomics in society. We contextualise issues such as…Read more
-
82The View of CRISPR Patents Through the Lens of Solidarity and the Public GoodAmerican Journal of Bioethics 18 (12): 54-56. 2018.
-
94One Health, Vaccines and Ebola: The Opportunities for Shared BenefitsJournal of Agricultural and Environmental Ethics 28 (6): 1011-1032. 2015.The 2013 Ebola virus outbreak in West Africa, as of writing, is declining in reported human cases and mortalities. The resulting devastation caused highlights how health systems, in particular in West Africa, and in terms of global pandemic planning, are ill prepared to react to zoonotic pathogens. In this paper we propose One Health as a strategy to prevent zoonotic outbreaks as a shared goal: that human and Great Ape vaccine trials could benefit both species. Only recently have two phase 2/3 E…Read more
-
6An Enquiry on the Ethics of One MedicineBioethics. forthcoming.One Medicine is not One Health. Although both concepts connect animal and human health, One Health has arguably become a frame for public health. This paper argues that One Medicine uniquely centres on animal and human patients and speaks to the equal interdependence of their health, though it has also (historically) been adopted as a response to the circumstances of living in and with nature. The evolution of One Medicine can be seen as ‘jumping together,’ or the consilience of ideas and discip…Read more
-
90Ethics and Security Aspects of Infectious Disease Control: Interdisciplinary Perspectives ed. by C. Enemark, M. Selgelid (review) (review)Asian Bioethics Review 5 (2): 162-168. 2013.
-
84Challenging the Production of Vaccines for a Future Influenza PandemicAsian Bioethics Review 5 (2): 110-130. 2013.
Halifax, Nova Scotia, Canada
Areas of Specialization
| Biomedical Ethics |
| Medical Ethics |
| Public Health |
| Biotechnology Ethics |
Areas of Interest
| Natural Sciences |
| Biomedical Ethics |
| Medical Ethics |
| Public Health |
| Biotechnology Ethics |